http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105943534-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81b72c21ca3bc0deda1bd75bd00b535a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
filingDate 2009-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a13a8d32a796e10833ae6087683a60c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c465b5f2d314f713ad7f9f70595aea36
publicationDate 2016-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105943534-A
titleOfInvention Topical LFA-1 antagonists for topical treatment of immune-related diseases
abstract The present invention provides specifically formulated LFA-1 antagonists or pharmaceutically acceptable salts thereof suitable for topical administration. In particular, said LFA-1 antagonists are particularly suitable for topical therapy due to their rapid systemic clearance. The present invention also includes methods of treating and preventing immune-related diseases using the LFA-1 topical formulations of the present invention.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114340630-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114452257-A
priorityDate 2008-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007142317-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006281739-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468365121
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465687672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468364389
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466794616
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467491814
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467397387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468375010
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468077407
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163929125
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467937748
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468288006

Total number of triples: 41.